Close

Mouse Monoclonal Antibody Discovery Service

Introduction Services Workflow Cases Why Choose Us? Related Services FAQs

The Enduring Value of Mouse Monoclonal Antibody

Fig 1. Mice. (Creative Biolabs Authorized)

The landscape of biomedical research and therapeutic development has been profoundly shaped by monoclonal antibodies (mAbs). For decades, mouse mAbs, primarily derived from hybridoma technology, have served as indispensable tools in diagnostics, preclinical research, and as foundational reagents for the development of humanized therapeutics.

However, traditional hybridoma approaches can face limitations, particularly concerning the discovery of antibodies against challenging targets. Phage display technology offers a powerful solution, enabling the in vitro selection of high-affinity binders from vast combinatorial libraries of antibody fragments. This methodology seamlessly links genotype to phenotype, revolutionizing the efficiency and scope of antibody discovery.

Mouse Monoclonal Antibody Discovery Services

Creative Biolabs, a leader in advanced antibody solutions, leverages our cutting-edge technology to provide comprehensive mouse monoclonal antibody discovery services. Our meticulously designed service is engineered to capitalize on the strengths of murine immunology while overcoming the limitations of conventional methods, delivering high-affinity, functionally relevant mouse antibody candidates for a wide spectrum of research, preclinical development, and diagnostic applications.

Creative Biolabs delivers an extensive suite of services for mouse antibody discovery via phage display, precisely tailored to accelerate your research and development objectives. Our integrated approach ensures the generation of highly specific, high-affinity mouse antibodies, from strategic antigen preparation to meticulous binder validation and downstream optimization. Our core offerings in this specialized domain encompass:

What Creative Biolabs Offering Features
Custom Phage Display Mouse Antibody Library Construction
Online Inquiry
Mouse Immune Antibody Library
  • Sourced from immunized mice to capture naturally matured, high-affinity antibody genes, ideal for complex or high-affinity targets.
  • Tailored for antigens benefiting from in vivo immune system maturation, providing antibodies with enhanced specificity and binding affinity.
Mouse Naïve Antibody Library
(Premade Library)
  • Sourced from diverse non-immunized mouse sources
  • Ideal for targeting non-immunogenic antigens, including those with low or absent immunogenicity
  • Premade mouse scFv/Fab library: Ready for immediate entry into the screening phase, reducing lead time in antibody discovery
Mouse Synthetic Antibody Library
  • Offer a highly controlled and precise diversity to explore antibody sequence space efficiently.
  • Enables fine-tuned selection for difficult targets, maximizing the likelihood of identifying high-quality leads with desirable properties.
High-Throughput Phage Display Library Screening
Online Inquiry
Solid-Phase Screening
Solution-Phase Screening
Cell-Based Screening
Protease Substrate Screening
  • Isolation of high-affinity, specific binders from both premade and custom mouse phage display libraries.
  • Iterative selection process with progressively stringent conditions ensures optimal enrichment of desirable clones.
  • Diverse screening methodologies employed to maximize the identification of high-quality binders, tailored to a wide range of target types.
Binder Validation and Characterization
Online Inquiry
Binding Affinity
Specificity
Stability
Initial Functional Properties
  • Affinity determination to accurately quantify the binding strength of the mouse antibody to its target
  • Stability assessment and enhancement to evaluate the antibody's structural integrity, resistance to aggregation, and overall developability under various stress conditions.
  • Functional properties characterization, for example, bispecific antibodies functional characterization to confirm the desired multi-targeting capabilities.

Our Streamlined Mouse Antibody Discovery Workflow

Our mouse monoclonal antibody discovery service features a meticulously structured, adaptable workflow, ensuring transparent and efficient progress from initial inquiry to final delivery. This proven pipeline integrates cutting-edge technologies at every crucial step, guaranteeing optimal outcomes for your mouse antibody development initiatives.

Initial Consultation & Project Alignment
Target Optimization & Preparation
Material Prep & Library Construction
Phage Display Library Screening
Binder Validation & Insightful Sequencing
Pilot Antibody Production
Comprehensive Antibody Characterization
Advanced Antibody Engineering

Begin with an in-depth discussion, working with you to define target characteristics, application needs, and desired outcomes, establishing clear objectives and project timelines together.

Case-Driven Discoveries: The Power of Our Mouse Antibody Discovery

How our process successfully addresses the challenges of developing specific antibodies for glycoprotein targets
Target Glycoprotein X
Control Glycoprotein C1
Glycoprotein C2
Glycoprotein C3
Challenge Developing antibodies that specifically bind to [Glycoprotein X], without cross-reacting with [Glycoprotein Y] or other similar glycoproteins.
Outcome We successfully identified several antibodies with high specificity for Glycoprotein X, which demonstrated no cross-reactivity with other glycoproteins.
1. Immunization Fig 2. Case for mouse immunization. (Creative Biolabs Original).
  • Custom Immunization Protocols: Tailored to maximize response to the target glycoprotein.
  • Continuous Monitoring: Regular assessments of antibody titers and specificity.
  • Selective Mouse Collection: Retaining only the most reactive donors for further development.
2. Immune Mouse scFv Library Construction
  • Custom Library Construction: The library is generated with a focus on the unique structure of the glycoprotein to minimize non-specific binding to similar proteins.
  • Focused Diversity: The diversity of the library is finely tuned to ensure a range of affinity and specificity suitable for the glycoprotein target.
Library Capacity Library Accuracy Theoretical Diversity
>109 >95% >107
3. In-solution Library Screening against Glycoprotein Target
Fig 3. Case for mouse antibody screening. (Creative Biolabs Original).
  • Selective Screening: Use stringent selection conditions to isolate binders with exceptional specificity for the glycoprotein of interest.
  • Cross-Reactivity Monitoring of Output: Extensive testing ensures that selected antibodies do not bind to other similar glycoproteins.
4. Binder Validation
Fig 4. Case for mouse antibody validation. (Creative Biolabs Original).
  • Binding Affinity and Specificity: Selected antibodies bind strongly to the target glycoprotein with no cross-reactivity to other glycoproteins.
Get in Touch for a Customized Quote

Why Choose Us?

Creative Biolabs is a global leader in mouse monoclonal antibody production, backed by profound expertise in phage display technology.

aaaaa
Leveraging Mouse Model Advantages

Mice offer unparalleled benefits for antibody discovery due to their strong immune response, genetic similarity to humans, and suitability for various experimental manipulations.

aaaaa
Advanced Phage Display Platform

Our platform excels at constructing high-quality, diverse immunized mouse antibody libraries.

aaaaa
High-Affinity Antibody Screening

We use sophisticated biopanning techniques to reliably screen for high-affinity monoclonal mouse antibodies.

aaaaa
Humanization & Affinity Maturation Solutions

We employ various solutions to further enhance the binding affinity and functional potency of lead mouse antibody candidates and translate for human therapeutic antibodies.

If you are looking for phage display technology services to develop prospective mouse monoclonal antibodies, please contact us with your specific requirements.

Other Species Antibody Solutions

Beyond our mouse monoclonal antibody discovery service, Creative Biolabs also provides a range of other phage display-based monoclonal antibody discovery services targeting other species. The specific species list is as follows:

FAQs

  1. Q: Why choose phage display for mouse monoclonal antibody discovery over traditional hybridoma?

    A: Phage display offers several key advantages, including in vitro screening against challenging antigens (e.g., toxic, poorly immunogenic, highly conserved, or conformational epitopes), rapid identification of high-affinity binders, and the ability to discover antibodies that might be difficult to obtain via in vivo immunization. It also provides direct access to antibody genes for immediate engineering.

  2. Q: What types of mouse antibody libraries does Creative Biolabs offer?

    A: We offer a diverse range of mouse antibody libraries to suit various research needs. This includes mouse immune libraries (from immunized mice), mouse naïve libraries (from healthy, unimmunized mice for broad target discovery), and mouse synthetic libraries (engineered with precise diversity). We also provide access to premade mouse antibody libraries for rapid screening.

  3. Q: What antibody formats can be discovered using your mouse phage display service?

    A: Our mouse monoclonal antibody discovery service primarily focuses on scFv and Fab formats, which are ideally suited for phage display. These fragments can be subsequently re-formatted into full-length IgGs or other customized formats for downstream applications.

  4. Q: How does Creative Biolabs ensure the high diversity and quality of its mouse antibody libraries?

    A: We employ rigorous molecular biology techniques, including optimized primer design and cloning strategies for mouse V-gene families, covering both kappa and lambda light chain isotypes. Our libraries are meticulously constructed to achieve high capacity (up to 109 to 1011) and diversity. We integrate sequencing validation to confirm library quality, minimize biases, and ensure high functional representation.

  5. Q: Is the intellectual property (IP) of the discovered mouse antibodies transferred to the client?

    A: Absolutely. All intellectual property rights to the custom mouse antibodies generated through our services are fully transferred to the client upon project completion. We operate under strict confidentiality protocols, and Non-Disclosure Agreements (NDAs) are standard.


All listed services and products are For Research Use Only. Do Not use in any diagnostic or therapeutic applications.

Online Inquiry
CONTACT US
USA:
Europe:
Germany:
Call us at:
USA:
UK:
Germany:
Fax:
Email:
Our customer service representatives are available 24 hours a day, 7 days a week. Contact Us
© 2026 Creative Biolabs. | Contact Us